Cite
Hypertrophic Cardiomyopathy Secondary to RAF1 Cysteine-Rich Domain Variants.
MLA
Fullenkamp, Dominic E., et al. “Hypertrophic Cardiomyopathy Secondary to RAF1 Cysteine-Rich Domain Variants.” Circulation. Genomic and Precision Medicine, vol. 16, no. 6, Dec. 2023, p. e004262. EBSCOhost, https://doi.org/10.1161/CIRCGEN.123.004262.
APA
Fullenkamp, D. E., Jorgensen, R. M., Leach, D. F., Sinha, A., Salamone, I. M., Johnston, J. R., Dellefave-Castillo, L. M., Choudhury, L., McNally, E. M., & Wilsbacher, L. D. (2023). Hypertrophic Cardiomyopathy Secondary to RAF1 Cysteine-Rich Domain Variants. Circulation. Genomic and Precision Medicine, 16(6), e004262. https://doi.org/10.1161/CIRCGEN.123.004262
Chicago
Fullenkamp, Dominic E, Ryan M Jorgensen, Desiree F Leach, Arjun Sinha, Isabella M Salamone, Jamie R Johnston, Lisa M Dellefave-Castillo, Lubna Choudhury, Elizabeth M McNally, and Lisa D Wilsbacher. 2023. “Hypertrophic Cardiomyopathy Secondary to RAF1 Cysteine-Rich Domain Variants.” Circulation. Genomic and Precision Medicine 16 (6): e004262. doi:10.1161/CIRCGEN.123.004262.